Furthermore, Knop et al. showed that the incretin action was deteriorated even in obese participants who have normal glucose tolerance in spite of their insulin-resistant state and that the coexistence of obesity and hyperglycemia resulted in the additive attenuation of the incretin effect [22]. The gene discussed is INS; the disease is obesity disorder.